{
  "id": 1508833,
  "title": "Rare gene variants may multiply Alzheimer's disease risk",
  "url": "https://urgent.news/2026/08/17/rare-gene-variants-may-multiply-alzheimers-disease-risk",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-17T16:00:03.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-rare-gene-variants-alzheimer-disease.html"
  },
  "original_language": "en",
  "account": "Recent research has revealed that specific gene variants, particularly in the PLCG2 gene, may significantly increase the risk of developing Alzheimer's disease. Alzheimer's is the most prevalent form of dementia globally, and its development is affected by both genetic and environmental elements. In recent years, the PLCG2 gene and its enzyme PLCγ2 have become crucial factors in understanding the risk of Alzheimer's.\n\nResearchers from the University of Eastern Finland and the French INSERM institute conducted a study in Nature Genetics, examining the impact of PLCG2 genetic variants on neuronal function. They found that rare, loss-of-function PLCG2 variants are linked to a tenfold higher risk of Alzheimer's disease compared to individuals without these variants.\n\nThe study also demonstrated that impaired PLCγ2 expression in human stem cell-derived neurons led to alterations in dendritic architecture and weakened synaptic function. Synapses, the connections between neurons, are particularly vulnerable in Alzheimer's disease, and synaptic dysfunction is one of the earliest signs of the condition. Additionally, reduced PLCγ2 activity resulted in increased levels of beta-amyloid and tau protein phosphorylation, two primary pathological indicators of Alzheimer's disease.\n\nThe research challenges the common belief that PLCG2 primarily influences Alzheimer's risk through its role in microglial cells, the brain's immune cells. Instead, the findings suggest that PLCγ2 is essential in neurons, and its reduced activity may initiate several molecular pathways that contribute to disease progression.\n\nThis investigation strengthens the understanding of PLCG2's role in Alzheimer's disease risk and offers valuable insights into the biological mechanisms behind the condition. The study indicates that increasing PLCγ2 signaling could potentially serve as a novel strategy for preventing or treating Alzheimer's disease in the future. However, further research and clinical validation are necessary to confirm these findings and explore their therapeutic potential.",
  "summary": "Alzheimer's disease is the most common form of dementia worldwide, and its development is influenced by a combination of genetic and environmental factors. In recent years, the PLCG2 gene and its encoded enzyme, PLCγ2, have emerged as some of the most important modifiers of Alzheimer's disease risk, as certain genetic variants in the gene appear to protect against the disease. For example, the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "PsyPost",
        "title": "Taxi and ambulance drivers show significantly lower Alzheimer’s risk in national mortality study",
        "url": "https://urgent.news/2026/08/17/taxi-and-ambulance-drivers-show-significantly-lower-alzheimers-risk",
        "published": "2026-08-17T12:00:15.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}